Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rhabdomyosarcoma | 22 | 2023 | 382 | 2.610 |
Why?
|
Bone Neoplasms | 22 | 2023 | 2530 | 1.010 |
Why?
|
Osteosarcoma | 11 | 2022 | 881 | 0.900 |
Why?
|
Rhabdomyosarcoma, Alveolar | 7 | 2017 | 41 | 0.670 |
Why?
|
Urogenital Neoplasms | 2 | 2018 | 137 | 0.670 |
Why?
|
Muscle Neoplasms | 2 | 2015 | 139 | 0.580 |
Why?
|
Cytodiagnosis | 5 | 2019 | 435 | 0.550 |
Why?
|
Teratoma | 2 | 2023 | 395 | 0.550 |
Why?
|
ras Proteins | 2 | 2018 | 1060 | 0.490 |
Why?
|
Biopsy, Fine-Needle | 6 | 2014 | 1094 | 0.450 |
Why?
|
Head and Neck Neoplasms | 4 | 2018 | 2736 | 0.440 |
Why?
|
Soft Tissue Neoplasms | 11 | 2018 | 1363 | 0.390 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 19 | 2023 | 11525 | 0.370 |
Why?
|
Rhabdomyosarcoma, Embryonal | 5 | 2022 | 102 | 0.360 |
Why?
|
Sarcoma | 7 | 2023 | 1897 | 0.340 |
Why?
|
Paired Box Transcription Factors | 5 | 2018 | 214 | 0.330 |
Why?
|
Child | 59 | 2023 | 77709 | 0.300 |
Why?
|
In Situ Hybridization, Fluorescence | 10 | 2021 | 2649 | 0.280 |
Why?
|
Anaplasia | 2 | 2020 | 16 | 0.280 |
Why?
|
Oncogene Proteins, Fusion | 8 | 2021 | 1581 | 0.280 |
Why?
|
Child, Preschool | 41 | 2023 | 41005 | 0.260 |
Why?
|
Surgical Flaps | 5 | 2008 | 1640 | 0.260 |
Why?
|
Infant | 33 | 2023 | 35134 | 0.250 |
Why?
|
Scapula | 2 | 1999 | 164 | 0.250 |
Why?
|
Pathology | 1 | 2007 | 272 | 0.240 |
Why?
|
Lymphangioma | 1 | 2023 | 65 | 0.220 |
Why?
|
Carcinoma, Papillary | 3 | 2018 | 783 | 0.220 |
Why?
|
Gene Fusion | 3 | 2022 | 371 | 0.220 |
Why?
|
Immunohistochemistry | 12 | 2015 | 11366 | 0.210 |
Why?
|
Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2021 | 45 | 0.200 |
Why?
|
Receptors, Cell Surface | 3 | 2015 | 2865 | 0.200 |
Why?
|
Disease-Free Survival | 12 | 2023 | 6896 | 0.200 |
Why?
|
Mitochondrial Diseases | 2 | 2015 | 320 | 0.190 |
Why?
|
Hedgehog Proteins | 2 | 2018 | 783 | 0.190 |
Why?
|
Myogenin | 4 | 2014 | 58 | 0.180 |
Why?
|
Muscle, Skeletal | 1 | 2015 | 4925 | 0.180 |
Why?
|
Neoplasm Recurrence, Local | 10 | 2023 | 9240 | 0.170 |
Why?
|
Lymphoma, T-Cell | 1 | 2002 | 299 | 0.170 |
Why?
|
Orbital Neoplasms | 2 | 2012 | 225 | 0.170 |
Why?
|
Diagnostic Imaging | 1 | 2013 | 3508 | 0.160 |
Why?
|
Cartilage | 3 | 1999 | 818 | 0.160 |
Why?
|
Doxorubicin | 7 | 2023 | 2234 | 0.160 |
Why?
|
Kidney Glomerulus | 1 | 2020 | 697 | 0.150 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2023 | 501 | 0.150 |
Why?
|
Adolescent | 34 | 2023 | 85779 | 0.150 |
Why?
|
Thyroid Neoplasms | 3 | 2018 | 2282 | 0.150 |
Why?
|
Translocation, Genetic | 4 | 2021 | 1420 | 0.150 |
Why?
|
Carcinoma, Papillary, Follicular | 1 | 2018 | 60 | 0.150 |
Why?
|
Temporal Bone | 1 | 2002 | 661 | 0.150 |
Why?
|
DNA Mutational Analysis | 5 | 2018 | 4185 | 0.150 |
Why?
|
Muscle Cells | 1 | 2018 | 197 | 0.150 |
Why?
|
Giant Cell Tumors | 2 | 1997 | 99 | 0.150 |
Why?
|
Neoplasms | 4 | 2019 | 21696 | 0.150 |
Why?
|
Humans | 102 | 2023 | 744366 | 0.150 |
Why?
|
Spleen | 1 | 2023 | 2362 | 0.150 |
Why?
|
Testicular Neoplasms | 1 | 2023 | 806 | 0.140 |
Why?
|
Meningitis, Aseptic | 1 | 1996 | 58 | 0.140 |
Why?
|
Vincristine | 6 | 2023 | 1039 | 0.140 |
Why?
|
Chorioamnionitis | 2 | 1994 | 155 | 0.140 |
Why?
|
Autopsy | 3 | 2014 | 1020 | 0.140 |
Why?
|
Gaucher Disease | 1 | 2017 | 112 | 0.140 |
Why?
|
Etoposide | 5 | 2023 | 641 | 0.140 |
Why?
|
Tongue Neoplasms | 1 | 2017 | 180 | 0.140 |
Why?
|
Combined Modality Therapy | 10 | 2023 | 8642 | 0.130 |
Why?
|
Obstetric Labor, Premature | 2 | 1994 | 279 | 0.130 |
Why?
|
Cytochrome Reductases | 1 | 2015 | 9 | 0.130 |
Why?
|
Growth Plate | 2 | 1999 | 274 | 0.130 |
Why?
|
Amniotic Fluid | 2 | 1994 | 370 | 0.130 |
Why?
|
Basal Cell Nevus Syndrome | 1 | 2015 | 40 | 0.130 |
Why?
|
Cisplatin | 6 | 2019 | 1662 | 0.130 |
Why?
|
Male | 60 | 2023 | 350115 | 0.120 |
Why?
|
Congresses as Topic | 1 | 2019 | 764 | 0.120 |
Why?
|
22q11 Deletion Syndrome | 1 | 2014 | 17 | 0.120 |
Why?
|
Microvilli | 1 | 2015 | 241 | 0.120 |
Why?
|
Forensic Medicine | 1 | 2014 | 64 | 0.120 |
Why?
|
Bone Transplantation | 1 | 1999 | 907 | 0.120 |
Why?
|
Mucolipidoses | 1 | 2015 | 82 | 0.120 |
Why?
|
Survival Rate | 7 | 2020 | 12788 | 0.120 |
Why?
|
Female | 65 | 2023 | 380193 | 0.120 |
Why?
|
Malabsorption Syndromes | 1 | 2015 | 135 | 0.120 |
Why?
|
Pathology, Clinical | 1 | 2018 | 368 | 0.120 |
Why?
|
Peptide Termination Factors | 1 | 2014 | 55 | 0.120 |
Why?
|
Skin Transplantation | 1 | 1999 | 1074 | 0.120 |
Why?
|
Acidosis, Lactic | 1 | 2015 | 142 | 0.120 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2014 | 351 | 0.110 |
Why?
|
Optic Atrophy | 1 | 2014 | 79 | 0.110 |
Why?
|
Gadolinium DTPA | 1 | 2017 | 836 | 0.110 |
Why?
|
Rhabdomyoma | 1 | 2013 | 57 | 0.110 |
Why?
|
Chondroma | 1 | 2013 | 58 | 0.110 |
Why?
|
Adrenal Insufficiency | 1 | 2015 | 184 | 0.110 |
Why?
|
Leigh Disease | 1 | 2014 | 75 | 0.110 |
Why?
|
Diagnosis, Differential | 9 | 2018 | 12961 | 0.110 |
Why?
|
Uterine Diseases | 1 | 1994 | 135 | 0.110 |
Why?
|
Sarcoma, Clear Cell | 1 | 2013 | 76 | 0.110 |
Why?
|
Contracture | 2 | 1994 | 224 | 0.110 |
Why?
|
Muscles | 1 | 2018 | 1614 | 0.110 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2016 | 324 | 0.110 |
Why?
|
Dactinomycin | 5 | 2018 | 318 | 0.110 |
Why?
|
Methotrexate | 5 | 2019 | 1728 | 0.110 |
Why?
|
Cardiotonic Agents | 1 | 2015 | 535 | 0.100 |
Why?
|
Terminology as Topic | 1 | 2019 | 1547 | 0.100 |
Why?
|
Gene Amplification | 1 | 1996 | 1063 | 0.100 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2020 | 2016 | 0.100 |
Why?
|
Metabolism, Inborn Errors | 1 | 2014 | 288 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 4 | 2016 | 6539 | 0.100 |
Why?
|
Heart Aneurysm | 1 | 2012 | 120 | 0.100 |
Why?
|
Amino Acid Metabolism, Inborn Errors | 1 | 2014 | 255 | 0.100 |
Why?
|
Prognosis | 12 | 2020 | 29060 | 0.100 |
Why?
|
Limb Deformities, Congenital | 1 | 1992 | 136 | 0.100 |
Why?
|
Neoplasm Metastasis | 6 | 2019 | 4851 | 0.100 |
Why?
|
Frameshift Mutation | 1 | 2013 | 399 | 0.100 |
Why?
|
Thyroid Nodule | 2 | 2016 | 750 | 0.100 |
Why?
|
Drug Resistance, Multiple | 2 | 2007 | 252 | 0.100 |
Why?
|
Genes, p53 | 1 | 2013 | 755 | 0.100 |
Why?
|
Young Adult | 13 | 2023 | 56429 | 0.090 |
Why?
|
Hypercalcemia | 1 | 2013 | 409 | 0.090 |
Why?
|
Cyclophosphamide | 5 | 2023 | 2242 | 0.090 |
Why?
|
Femur | 2 | 2013 | 1297 | 0.090 |
Why?
|
Follow-Up Studies | 10 | 2020 | 39052 | 0.090 |
Why?
|
Antibodies, Monoclonal | 6 | 2023 | 9274 | 0.090 |
Why?
|
Paraganglioma | 1 | 2012 | 143 | 0.090 |
Why?
|
Adult | 32 | 2023 | 214052 | 0.090 |
Why?
|
Osteotomy | 1 | 2015 | 822 | 0.090 |
Why?
|
Ornithine | 1 | 2009 | 78 | 0.090 |
Why?
|
Thyroid Gland | 1 | 2016 | 1173 | 0.090 |
Why?
|
Siblings | 1 | 2014 | 854 | 0.090 |
Why?
|
Microfilament Proteins | 1 | 2015 | 1152 | 0.090 |
Why?
|
Foot Ulcer | 1 | 2009 | 59 | 0.090 |
Why?
|
World Health Organization | 1 | 2015 | 1318 | 0.080 |
Why?
|
Cataract | 1 | 2015 | 834 | 0.080 |
Why?
|
Infant, Newborn | 10 | 2023 | 25628 | 0.080 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2018 | 2110 | 0.080 |
Why?
|
Topotecan | 3 | 2009 | 137 | 0.080 |
Why?
|
Transforming Growth Factor beta | 1 | 1996 | 2007 | 0.080 |
Why?
|
Heart Neoplasms | 1 | 2012 | 374 | 0.080 |
Why?
|
Treatment Outcome | 15 | 2018 | 63107 | 0.080 |
Why?
|
RNA-Binding Protein EWS | 3 | 2021 | 216 | 0.080 |
Why?
|
Skin | 2 | 2009 | 4372 | 0.080 |
Why?
|
PAX7 Transcription Factor | 3 | 2014 | 53 | 0.080 |
Why?
|
Pressure Ulcer | 1 | 2009 | 155 | 0.080 |
Why?
|
Sarcoidosis | 1 | 2013 | 506 | 0.080 |
Why?
|
Abnormalities, Multiple | 2 | 2012 | 1416 | 0.080 |
Why?
|
Mutation | 4 | 2018 | 29786 | 0.080 |
Why?
|
Sclerosis | 2 | 2005 | 213 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 6 | 2014 | 4751 | 0.080 |
Why?
|
Histiocytoma, Malignant Fibrous | 1 | 2007 | 63 | 0.080 |
Why?
|
Ear Neoplasms | 1 | 2008 | 117 | 0.080 |
Why?
|
Ear, External | 1 | 2008 | 161 | 0.070 |
Why?
|
Cell Nucleus | 1 | 2016 | 2969 | 0.070 |
Why?
|
Neoadjuvant Therapy | 2 | 2015 | 2727 | 0.070 |
Why?
|
Ifosfamide | 3 | 2015 | 228 | 0.070 |
Why?
|
Heel | 2 | 2009 | 36 | 0.070 |
Why?
|
Extremities | 1 | 1992 | 866 | 0.070 |
Why?
|
Polymerase Chain Reaction | 1 | 1996 | 6171 | 0.070 |
Why?
|
Receptors, Progesterone | 1 | 2011 | 1098 | 0.070 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2013 | 964 | 0.070 |
Why?
|
Ectromelia | 2 | 1999 | 31 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2020 | 2200 | 0.070 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2007 | 250 | 0.070 |
Why?
|
North America | 2 | 2023 | 1249 | 0.070 |
Why?
|
Contrast Media | 2 | 2017 | 5300 | 0.070 |
Why?
|
Antigens, CD | 1 | 1996 | 4026 | 0.070 |
Why?
|
Image Enhancement | 1 | 2017 | 2921 | 0.070 |
Why?
|
Germ-Line Mutation | 1 | 2013 | 1788 | 0.070 |
Why?
|
Pregnancy Complications, Infectious | 2 | 1994 | 2026 | 0.070 |
Why?
|
Hand Deformities, Congenital | 2 | 1999 | 146 | 0.060 |
Why?
|
Genetic Variation | 1 | 2020 | 6542 | 0.060 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 514 | 0.060 |
Why?
|
Hepatolenticular Degeneration | 1 | 2005 | 69 | 0.060 |
Why?
|
Knee Joint | 1 | 2013 | 1680 | 0.060 |
Why?
|
Kidney Diseases | 2 | 2014 | 2148 | 0.060 |
Why?
|
Australia | 2 | 2019 | 1167 | 0.060 |
Why?
|
Survival Analysis | 7 | 2020 | 10252 | 0.060 |
Why?
|
Chondrosarcoma | 2 | 1997 | 309 | 0.060 |
Why?
|
Interleukin-1 | 2 | 1998 | 1263 | 0.060 |
Why?
|
Heart Arrest | 1 | 1993 | 1470 | 0.060 |
Why?
|
Mitral Valve | 1 | 2012 | 1491 | 0.060 |
Why?
|
Receptors, Estrogen | 1 | 2011 | 2190 | 0.060 |
Why?
|
Liver Failure, Acute | 1 | 2005 | 165 | 0.060 |
Why?
|
Hepatitis, Autoimmune | 1 | 2005 | 141 | 0.060 |
Why?
|
Lymphoma, B-Cell | 1 | 2009 | 931 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 3 | 2020 | 17446 | 0.050 |
Why?
|
Sacrum | 1 | 2005 | 288 | 0.050 |
Why?
|
Retrospective Studies | 18 | 2023 | 77460 | 0.050 |
Why?
|
Neoplasms, Connective Tissue | 1 | 2002 | 40 | 0.050 |
Why?
|
Liver | 2 | 2017 | 7475 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 7 | 2017 | 35425 | 0.050 |
Why?
|
Myocardial Ischemia | 1 | 2013 | 2148 | 0.050 |
Why?
|
Burns | 1 | 1994 | 1815 | 0.050 |
Why?
|
In Situ Hybridization | 5 | 1998 | 1950 | 0.050 |
Why?
|
Glucose | 1 | 1994 | 4398 | 0.050 |
Why?
|
Interleukin-6 | 3 | 1998 | 3203 | 0.050 |
Why?
|
Staining and Labeling | 4 | 2018 | 1101 | 0.050 |
Why?
|
Paraffin Embedding | 3 | 2013 | 299 | 0.050 |
Why?
|
Coronary Vessels | 1 | 2013 | 3107 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2017 | 4034 | 0.050 |
Why?
|
Peptide Hormones | 1 | 2002 | 134 | 0.050 |
Why?
|
Receptor, erbB-2 | 1 | 2011 | 2417 | 0.050 |
Why?
|
Cardiomyopathies | 1 | 1993 | 1912 | 0.050 |
Why?
|
Bile Duct Neoplasms | 1 | 2007 | 567 | 0.050 |
Why?
|
MyoD Protein | 3 | 2007 | 151 | 0.050 |
Why?
|
Barrett Esophagus | 2 | 1998 | 494 | 0.050 |
Why?
|
Sensitivity and Specificity | 7 | 2014 | 14723 | 0.050 |
Why?
|
Interferon-alpha | 2 | 2015 | 895 | 0.050 |
Why?
|
Cell Differentiation | 1 | 2018 | 11486 | 0.050 |
Why?
|
Myocardium | 1 | 2013 | 4772 | 0.050 |
Why?
|
Risk Factors | 5 | 2022 | 72296 | 0.050 |
Why?
|
DNA | 1 | 2014 | 7294 | 0.040 |
Why?
|
Liver Neoplasms | 3 | 2011 | 4253 | 0.040 |
Why?
|
Aortic Valve Stenosis | 1 | 2012 | 1965 | 0.040 |
Why?
|
Polyethylene Glycols | 2 | 2015 | 1182 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 7914 | 0.040 |
Why?
|
Ankle | 1 | 1982 | 327 | 0.040 |
Why?
|
Schwann Cells | 1 | 2000 | 196 | 0.040 |
Why?
|
Cranial Nerve Neoplasms | 1 | 2000 | 129 | 0.040 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2022 | 903 | 0.040 |
Why?
|
Femur Head Necrosis | 1 | 1999 | 132 | 0.040 |
Why?
|
Middle Aged | 19 | 2020 | 213390 | 0.040 |
Why?
|
RNA-Binding Proteins | 1 | 2007 | 1903 | 0.040 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2005 | 808 | 0.040 |
Why?
|
Pathology, Molecular | 1 | 2021 | 326 | 0.040 |
Why?
|
Epiphyses | 1 | 1999 | 189 | 0.040 |
Why?
|
Histological Techniques | 1 | 1998 | 198 | 0.040 |
Why?
|
Wound Healing | 1 | 2009 | 2785 | 0.040 |
Why?
|
Synovitis, Pigmented Villonodular | 1 | 1998 | 34 | 0.040 |
Why?
|
Trigeminal Nerve | 1 | 2000 | 249 | 0.040 |
Why?
|
Pain | 1 | 2013 | 4988 | 0.040 |
Why?
|
Heart Defects, Congenital | 1 | 2014 | 4583 | 0.040 |
Why?
|
Genes, MDR | 1 | 1997 | 37 | 0.040 |
Why?
|
Osteoclasts | 2 | 2002 | 729 | 0.040 |
Why?
|
Osteochondroma | 1 | 1997 | 47 | 0.040 |
Why?
|
Ankle Injuries | 1 | 2001 | 331 | 0.040 |
Why?
|
Gene Expression | 4 | 2013 | 7798 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 1 | 2009 | 4554 | 0.040 |
Why?
|
Meningitis, Viral | 1 | 1996 | 50 | 0.040 |
Why?
|
Kidney Neoplasms | 1 | 2013 | 4262 | 0.040 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7282 | 0.040 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2017 | 367 | 0.030 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2017 | 373 | 0.030 |
Why?
|
Cytogenetic Analysis | 2 | 2007 | 295 | 0.030 |
Why?
|
DNA, Neoplasm | 2 | 2013 | 1758 | 0.030 |
Why?
|
Metalloendopeptidases | 1 | 1998 | 396 | 0.030 |
Why?
|
Morocco | 1 | 2015 | 28 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 1998 | 4424 | 0.030 |
Why?
|
Oxidoreductases Acting on Sulfur Group Donors | 1 | 2015 | 32 | 0.030 |
Why?
|
Cartilage Diseases | 1 | 1997 | 160 | 0.030 |
Why?
|
Adenocarcinoma | 2 | 2009 | 6364 | 0.030 |
Why?
|
Metaplasia | 1 | 1996 | 313 | 0.030 |
Why?
|
Giant Cell Tumor of Bone | 1 | 1996 | 116 | 0.030 |
Why?
|
Sarcoma, Synovial | 1 | 1996 | 167 | 0.030 |
Why?
|
DNA Probes | 1 | 1996 | 560 | 0.030 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 1996 | 294 | 0.030 |
Why?
|
Aged | 15 | 2016 | 163288 | 0.030 |
Why?
|
Neurons | 1 | 2014 | 9340 | 0.030 |
Why?
|
Microscopy, Electron | 2 | 2000 | 2646 | 0.030 |
Why?
|
Ventricular Dysfunction | 1 | 2015 | 143 | 0.030 |
Why?
|
Signal Transduction | 1 | 2018 | 23404 | 0.030 |
Why?
|
Methylmalonyl-CoA Mutase | 1 | 2014 | 22 | 0.030 |
Why?
|
Ploidies | 1 | 1994 | 281 | 0.030 |
Why?
|
Radiotherapy | 2 | 2012 | 1533 | 0.030 |
Why?
|
Iopamidol | 1 | 2014 | 191 | 0.030 |
Why?
|
Neoplasm Staging | 5 | 2010 | 11031 | 0.030 |
Why?
|
Aged, 80 and over | 8 | 2016 | 57776 | 0.030 |
Why?
|
Diet, Protein-Restricted | 1 | 2014 | 71 | 0.030 |
Why?
|
Carcinoma, Small Cell | 1 | 1996 | 420 | 0.030 |
Why?
|
Biopsy | 3 | 2002 | 6755 | 0.030 |
Why?
|
HMGA2 Protein | 1 | 2014 | 123 | 0.030 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2014 | 170 | 0.030 |
Why?
|
Intestinal Neoplasms | 1 | 1996 | 319 | 0.030 |
Why?
|
Liver Transplantation | 1 | 2005 | 2119 | 0.030 |
Why?
|
Asia | 1 | 2015 | 609 | 0.030 |
Why?
|
Ossification, Heterotopic | 1 | 1996 | 239 | 0.030 |
Why?
|
Cohort Studies | 4 | 2019 | 40559 | 0.030 |
Why?
|
Mediastinal Neoplasms | 1 | 1996 | 423 | 0.030 |
Why?
|
Nephrocalcinosis | 1 | 2013 | 48 | 0.030 |
Why?
|
Consanguinity | 1 | 2015 | 454 | 0.030 |
Why?
|
Nephritis | 1 | 2014 | 159 | 0.030 |
Why?
|
Forkhead Transcription Factors | 2 | 2013 | 1613 | 0.030 |
Why?
|
Bone Resorption | 1 | 1997 | 723 | 0.030 |
Why?
|
Clinical Trials, Phase IV as Topic | 1 | 2012 | 27 | 0.030 |
Why?
|
Predictive Value of Tests | 4 | 2009 | 15078 | 0.030 |
Why?
|
Simplexvirus | 1 | 1996 | 803 | 0.030 |
Why?
|
Amniotic Band Syndrome | 1 | 1992 | 22 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2014 | 20130 | 0.030 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2005 | 2249 | 0.030 |
Why?
|
Review Literature as Topic | 1 | 2015 | 336 | 0.030 |
Why?
|
Ohio | 1 | 2013 | 337 | 0.030 |
Why?
|
von Willebrand Factor | 1 | 1996 | 669 | 0.030 |
Why?
|
Foot Deformities, Congenital | 1 | 1992 | 59 | 0.030 |
Why?
|
Fatal Outcome | 2 | 1996 | 1851 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2014 | 3921 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2014 | 553 | 0.030 |
Why?
|
Esophagus | 1 | 1998 | 1019 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2007 | 5172 | 0.030 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2014 | 300 | 0.030 |
Why?
|
History, Ancient | 1 | 2012 | 212 | 0.030 |
Why?
|
Hydronephrosis | 1 | 2013 | 269 | 0.030 |
Why?
|
Kidney Tubules, Proximal | 1 | 2014 | 416 | 0.030 |
Why?
|
Shoulder | 1 | 1994 | 299 | 0.030 |
Why?
|
Lymphatic Diseases | 1 | 2013 | 323 | 0.030 |
Why?
|
Mitochondria | 2 | 2015 | 3514 | 0.020 |
Why?
|
Axilla | 1 | 1994 | 597 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 2016 | 1180 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2015 | 3480 | 0.020 |
Why?
|
Vitamin B 12 | 1 | 2014 | 527 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2016 | 12356 | 0.020 |
Why?
|
Thyroidectomy | 1 | 2016 | 879 | 0.020 |
Why?
|
Developing Countries | 1 | 2023 | 2815 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2020 | 2645 | 0.020 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2012 | 194 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2023 | 3486 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2008 | 5263 | 0.020 |
Why?
|
Fibula | 1 | 1992 | 269 | 0.020 |
Why?
|
Hepatocytes | 1 | 2017 | 1211 | 0.020 |
Why?
|
Fetal Death | 1 | 2012 | 448 | 0.020 |
Why?
|
Mosaicism | 1 | 1993 | 441 | 0.020 |
Why?
|
Lung Neoplasms | 2 | 2009 | 13104 | 0.020 |
Why?
|
DNA, Viral | 1 | 1996 | 2227 | 0.020 |
Why?
|
Histocytological Preparation Techniques | 1 | 2009 | 30 | 0.020 |
Why?
|
Vesico-Ureteral Reflux | 1 | 2013 | 427 | 0.020 |
Why?
|
Atrophy | 1 | 2014 | 1584 | 0.020 |
Why?
|
Radius | 1 | 1992 | 422 | 0.020 |
Why?
|
Research Report | 1 | 2012 | 355 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2016 | 1257 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 1992 | 987 | 0.020 |
Why?
|
Karyotyping | 2 | 2006 | 1243 | 0.020 |
Why?
|
Ultrasonography | 2 | 2013 | 5984 | 0.020 |
Why?
|
Bone Remodeling | 1 | 1992 | 575 | 0.020 |
Why?
|
Triiodothyronine | 1 | 2010 | 494 | 0.020 |
Why?
|
Pediatrics | 1 | 2004 | 3475 | 0.020 |
Why?
|
Prospective Studies | 5 | 2016 | 53290 | 0.020 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2012 | 841 | 0.020 |
Why?
|
Europe | 1 | 2015 | 3338 | 0.020 |
Why?
|
Incidental Findings | 1 | 2013 | 689 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2016 | 3616 | 0.020 |
Why?
|
Kidney | 2 | 2014 | 7184 | 0.020 |
Why?
|
Base Sequence | 2 | 1996 | 12797 | 0.020 |
Why?
|
Mitochondrial Proteins | 1 | 2014 | 994 | 0.020 |
Why?
|
Nephrectomy | 1 | 2013 | 1050 | 0.020 |
Why?
|
Brain | 1 | 2014 | 26388 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2023 | 10483 | 0.020 |
Why?
|
Proteins | 1 | 2002 | 6100 | 0.020 |
Why?
|
Range of Motion, Articular | 1 | 1994 | 1578 | 0.020 |
Why?
|
Genomics | 1 | 2023 | 5717 | 0.020 |
Why?
|
Phenotype | 2 | 2015 | 16367 | 0.020 |
Why?
|
Treatment Failure | 2 | 2004 | 2618 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2013 | 1265 | 0.020 |
Why?
|
Thyrotropin | 1 | 2010 | 849 | 0.020 |
Why?
|
Tibia | 1 | 1992 | 1077 | 0.020 |
Why?
|
Chromosome Banding | 1 | 2006 | 278 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2010 | 2031 | 0.020 |
Why?
|
Chromosome Aberrations | 1 | 1993 | 1813 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 1996 | 18111 | 0.020 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2006 | 197 | 0.020 |
Why?
|
Algorithms | 1 | 2006 | 13882 | 0.020 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2006 | 105 | 0.020 |
Why?
|
Radiography | 2 | 2013 | 7023 | 0.020 |
Why?
|
Gene Deletion | 1 | 2013 | 2751 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3595 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2020 | 14561 | 0.020 |
Why?
|
Pilot Projects | 1 | 2018 | 8319 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2015 | 6621 | 0.020 |
Why?
|
Cystoscopy | 1 | 2005 | 134 | 0.020 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2006 | 326 | 0.020 |
Why?
|
Precancerous Conditions | 1 | 1992 | 975 | 0.020 |
Why?
|
Pregnancy | 4 | 2012 | 29144 | 0.020 |
Why?
|
Family | 1 | 2015 | 3147 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2011 | 20824 | 0.010 |
Why?
|
Urine | 1 | 2005 | 370 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2013 | 2108 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2887 | 0.010 |
Why?
|
Bacteria | 1 | 1994 | 2115 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9312 | 0.010 |
Why?
|
Swine | 1 | 2013 | 5918 | 0.010 |
Why?
|
Biological Assay | 1 | 2006 | 652 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18373 | 0.010 |
Why?
|
Flow Cytometry | 2 | 2008 | 5974 | 0.010 |
Why?
|
Back | 1 | 1982 | 66 | 0.010 |
Why?
|
Mucins | 1 | 2005 | 564 | 0.010 |
Why?
|
Leg Length Inequality | 1 | 1982 | 55 | 0.010 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 1692 | 0.010 |
Why?
|
Reference Values | 1 | 2009 | 4982 | 0.010 |
Why?
|
Macrophages | 1 | 1996 | 5660 | 0.010 |
Why?
|
Esophageal Neoplasms | 1 | 1992 | 1585 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2014 | 4042 | 0.010 |
Why?
|
Biopsy, Needle | 2 | 1996 | 1641 | 0.010 |
Why?
|
Life Tables | 1 | 2001 | 370 | 0.010 |
Why?
|
Parathyroid Hormone-Related Protein | 1 | 2002 | 331 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2010 | 19905 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9735 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2014 | 8949 | 0.010 |
Why?
|
Mice | 2 | 2020 | 81201 | 0.010 |
Why?
|
Risk Assessment | 1 | 2022 | 23336 | 0.010 |
Why?
|
Calcium | 1 | 2013 | 5755 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2001 | 8861 | 0.010 |
Why?
|
Bronchiolitis Obliterans | 1 | 2001 | 194 | 0.010 |
Why?
|
Animals | 3 | 2020 | 168768 | 0.010 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 2000 | 335 | 0.010 |
Why?
|
Time Factors | 2 | 2015 | 40075 | 0.010 |
Why?
|
Radiotherapy Dosage | 1 | 2006 | 2879 | 0.010 |
Why?
|
Melphalan | 1 | 2001 | 431 | 0.010 |
Why?
|
Echocardiography | 1 | 2012 | 5099 | 0.010 |
Why?
|
S100 Proteins | 1 | 2000 | 259 | 0.010 |
Why?
|
Bone Marrow Diseases | 1 | 2001 | 231 | 0.010 |
Why?
|
Vimentin | 1 | 2000 | 262 | 0.010 |
Why?
|
Research Design | 1 | 2014 | 5984 | 0.010 |
Why?
|
Neurofibromin 2 | 1 | 2000 | 267 | 0.010 |
Why?
|
United States | 3 | 2018 | 69872 | 0.010 |
Why?
|
Medical Records | 1 | 2004 | 1413 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2008 | 5077 | 0.010 |
Why?
|
Disease Progression | 1 | 2015 | 13286 | 0.010 |
Why?
|
Foot | 1 | 1982 | 527 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2005 | 2700 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2005 | 1739 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2001 | 13693 | 0.010 |
Why?
|
Ankle Joint | 1 | 2001 | 411 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 1997 | 427 | 0.010 |
Why?
|
Osteoblasts | 1 | 2002 | 1166 | 0.010 |
Why?
|
Cecal Neoplasms | 1 | 1996 | 29 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 1994 | 25039 | 0.010 |
Why?
|
Parathyroid Hormone | 1 | 2002 | 1800 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2001 | 1771 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2011 | 8432 | 0.010 |
Why?
|
Remission Induction | 1 | 2001 | 2385 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2009 | 12025 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18034 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2007 | 3707 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 1996 | 1799 | 0.010 |
Why?
|
Quality of Life | 1 | 2014 | 12802 | 0.010 |
Why?
|
Bone Diseases | 1 | 1997 | 416 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1995 | 1581 | 0.010 |
Why?
|
Oligonucleotides, Antisense | 1 | 1995 | 433 | 0.010 |
Why?
|
Anus Neoplasms | 1 | 1996 | 332 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2001 | 6366 | 0.010 |
Why?
|
Prevalence | 1 | 2008 | 15221 | 0.010 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 1993 | 417 | 0.010 |
Why?
|
Incidence | 2 | 2004 | 20952 | 0.010 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 1993 | 462 | 0.010 |
Why?
|
Databases, Factual | 1 | 2006 | 7730 | 0.010 |
Why?
|
Esophagoscopy | 1 | 1992 | 390 | 0.010 |
Why?
|
X Chromosome | 1 | 1993 | 814 | 0.010 |
Why?
|
Data Collection | 1 | 1998 | 3339 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 1994 | 3508 | 0.000 |
Why?
|
Chromosome Deletion | 1 | 1993 | 1401 | 0.000 |
Why?
|
Multivariate Analysis | 1 | 2001 | 12244 | 0.000 |
Why?
|
Population Surveillance | 1 | 1998 | 2616 | 0.000 |
Why?
|
Fetal Diseases | 1 | 1993 | 903 | 0.000 |
Why?
|
Sepsis | 1 | 2001 | 2593 | 0.000 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1993 | 3873 | 0.000 |
Why?
|
Bone and Bones | 1 | 1997 | 2576 | 0.000 |
Why?
|
Health Care Costs | 1 | 1998 | 3208 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 2002 | 15535 | 0.000 |
Why?
|
Placenta | 1 | 1993 | 1699 | 0.000 |
Why?
|
Colonic Neoplasms | 1 | 1996 | 2542 | 0.000 |
Why?
|
Membrane Proteins | 1 | 2000 | 7882 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1998 | 13035 | 0.000 |
Why?
|
Cell Line | 1 | 1993 | 16000 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1993 | 19233 | 0.000 |
Why?
|